AXA Signs Cooperation Agreement with Hainan Boao Lecheng Administration

Jointly explore innovative medical insurance services to provide customers with diverse and high-quality healthcare options

HONG KONG, Aug. 8, 2025 /PRNewswire/ -- AXA China Region Insurance Company (Bermuda) Limited ("AXA") formally signed an official cooperation agreement with Hainan Boao Lecheng International Medical Tourism Pilot Zone Administration ("Lecheng Administration"). The partnership aims jointly explore more innovative medical insurance models and leverage the top-tier medical resources of Hainan Boao Lecheng to provide customers with more high-quality cross-border medical options.

The Hainan Boao Lecheng International Medical Tourism Pilot Zone ("the Pilot Zone") was approved by the State Council^[1] in 2013 as the only medical special zone in China, enjoying preferential policies covering licensed medical services, operations, research, and international exchanges. Since approval, the Pilot Zone has attracted leading medical institutions and specialist teams, introducing advanced international treatment protocols, innovative pharmaceuticals, and medical devices into China for trial use – including therapies for rare diseases and cutting-edge cancer treatments. Meanwhile, AXA has partnered with China Biotech Services Holdings Limited to explore Boron Neutron Capture Therapy ("BNCT"), a pioneering initiative now being established within the Pilot Zone.

Janet Lee, Chief Life and Health Insurance Officer, AXA Hong Kong and Macau, said, "We are honoured to have signed a cooperation agreement with the Lecheng Administration. As a pioneer in China's medical opening-up, Hainan Boao Lecheng benefits from unique policy advantages and strong support from global healthcare resources. This collaboration will enable AXA to explore innovative healthcare solutions and integrate them into our insurance offerings, providing customers with broader access to advanced treatment options. We look forward to deepening our partnership with Lecheng and other stakeholders to develop innovative medical models, enabling more customers to benefit from Lecheng's licensed medicines, medical devices, and cutting-edge technologies."

About AXA Hong Kong and Macau

AXA Hong Kong and Macau is a member of the AXA Group, a leading global insurer with presence in 50 markets and serving 95 million customers worldwide. Our purpose is to act for human progress by protecting what matters.

As one of the most diversified insurers in Hong Kong, we offer integrated solutions across Life, Health and General Insurance. We are the largest General Insurance provider and a major Health and Employee Benefits provider. Our aim is to not only be the insurer to provide comprehensive protection to our customers, but also a holistic partner to the individuals, businesses and community we serve. At the core of our service commitment is continuous product & service innovation and customer experience enrichment, which is achieved through actively listening to our customers' needs and leveraging and investing in technology and digital transformation.

We embrace our responsibility to be a driving force against climate change and a force for good to create shared value for our community. We are proud to be the first to address the importance of mental health through different products and services and thought leading iconic research. Our overall Sustainability Strategy, with emphasis on climate strategy and biodiversity commitment, is developed based on TCFD recommendations. We are committed to integrating environmental, social and governance factors across our business and strive to contribute to a sustainable future through 3 distinct roles - as an investor, an insurer and an exemplary company.

THIS PRESS RELEASE IS AVAILABLE ON AXA'S WEBSITE: AXA.COM.HK

IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS

Certain statements contained herein may be forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause AXA's actual results to differ materially from those expressed or implied in the forward-looking statements. Please refer to Part 4 - "Risk factors and risk management" of AXA's Universal Registration Document for the year ended December 31, 2019, for a description of certain important factors, risks and uncertainties that may affect AXA's business, and/or results of operations. AXA undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise, except as part of applicable regulatory or legal obligations.

source: AXA Hong Kong & Macau